Skip to content
WeighLab
Menu
Ranked #187 · Grade C

NativeMed review

NativeMed is a direct-to-consumer telehealth site selling compounded semaglutide and compounded tirzepatide as flat-rate, any-dose weekly injections, with no membership fee and free 48-hour shipping advertised.

Visit NativeMed Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$149/mo (all doses, 3-month plan, compounded)
Tirzepatide
$183/mo (all doses, 3-month plan, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$1,788

Tirzepatide · modeled / year

$2,196

Pricing verified August 2026

The Index scorecard

NativeMed scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month72/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight62/100
Contract Flexibility47/100

Where the value is

  • Flat 'same price any dose' pricing removes the dose-tier price-creep common at other compounded GLP-1 sites
  • No stated membership/platform fee stacked on top of the medication price
  • Free 48-hour shipping advertised on the homepage
  • Semaglutide starts at $149/mo (vs. its own listed $299 regular price) and tirzepatide at $183/mo (vs. $399)

The tradeoffs

  • The site's own '3-month starter' pricing table implies the real first-month charge ($179-$259) runs higher than the advertised $149-$183/mo headline rate
  • No published list of which U.S. states NativeMed actually serves — a buyer can't confirm eligibility before starting the intake
  • No dosing-tier detail (starting dose, titration schedule) is disclosed on the product pages
  • Compounded, not FDA-approved brand-name product; not insurance-billable
  • FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Cost-first shoppers who want a flat monthly rate regardless of dose, without a separate membership fee. NativeMed is a direct-to-consumer telehealth site selling compounded semaglutide and compounded tirzepatide as flat-rate, any-dose weekly injections, with no membership fee and free 48-hour shipping advertised.

Ranked #187 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NativeMed.

The 24 programs nearest this one

Pricing, states and verification reflect NativeMed's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NativeMed's site. Not medical advice; see our disclosure.

← Back to the value leaderboard